Daiichi-Sankyo (Japan)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
5.5K
Total Open
Publications
2.8K
Total
Citations
172K
Open Access
Percentage
51%
Total
Publications
5.5K
Total Open
Publications
2.8K
Total
Citations
172K
Breakdown
Publisher Open
26%
Both
19%
Other Platform Open
6%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
544
Hybrid 37%
907
No Guarantees 41%
1K
Other Platform Open
Domain 84%
1.2K
Institution 15%
214
Public 13%
176
Other Internet 9%
122
Preprint 6%
83
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.2K |
Europe PMC | Domain | 554 |
Figshare | Public | 169 |
DOI | Other Internet | 160 |
Semantic Scholar | Public | 122 |
Research Square | Preprint | 43 |
California Digital Library - eScholarship | Other Internet | 32 |
University of Birmingham - University of Birmingham Research Portal | Institution | 29 |
University of California - eScholarship University of California | Institution | 24 |
bioRxiv | Preprint | 23 |